Optimizing the use of quality control samples for signal drift correction in large-scale urine metabolic profiling studies.

The evident importance of metabolic profiling for biomarker discovery and hypothesis generation has led to interest in incorporating this technique into large-scale studies, e.g., clinical and molecular phenotyping studies. Nevertheless, these lengthy studies mandate the use of analytical methods with proven reproducibility. An integrated experimental plan for LC-MS profiling of urine, involving sample sequence design and postacquisition correction routines, has been developed. This plan is based on the optimization of the frequency of analyzing identical quality control (QC) specimen injections and using the QC intensities of each metabolite feature to construct a correction trace for all the samples. The QC-based methods were tested against other current correction practices, such as total intensity normalization. The evaluation was based on the reproducibility obtained from technical replicates of 46 samples and showed the feature-based signal correction (FBSC) methods to be superior to other methods, resulting in ~1000 and 600 metabolite features with coefficient of variation (CV) < 15% within and between two blocks, respectively. Additionally, the required frequency of QC sample injection was investigated and the best signal correction results were achieved with at least one QC injection every 2 h of urine sample injections (n = 10). Higher rates of QC injections (1 QC/h) resulted in slightly better correction but at the expense of longer total analysis time.

[1]  Peggy H. Wong,et al.  Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group. , 2011, Pharmacogenomics.

[2]  Joshua D. Knowles,et al.  Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry , 2011, Nature Protocols.

[3]  E. Want,et al.  Cross-platform comparison of Caenorhabditis elegans tissue extraction strategies for comprehensive metabolome coverage. , 2011, Analytical chemistry.

[4]  Marc Chadeau-Hyam,et al.  Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study. , 2010, Journal of proteome research.

[5]  R. Breitling,et al.  Metabolomics to Unveil and Understand Phenotypic Diversity between Pathogen Populations , 2010, PLoS neglected tropical diseases.

[6]  Jeremiah Stamler,et al.  Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology. , 2010, Journal of clinical epidemiology.

[7]  T. Ebbels,et al.  Optimization and evaluation of metabolite extraction protocols for untargeted metabolic profiling of liver samples by UPLC-MS. , 2010, Analytical chemistry.

[8]  E. Want,et al.  Global metabolic profiling procedures for urine using UPLC–MS , 2010, Nature Protocols.

[9]  Lothar Willmitzer,et al.  Discrimination of wine attributes by metabolome analysis. , 2010, Analytical chemistry.

[10]  R. Krauss,et al.  Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study , 2010, Metabolomics.

[11]  Huiru Tang,et al.  Combined NMR and LC-DAD-MS analysis reveals comprehensive metabonomic variations for three phenotypic cultivars of Salvia Miltiorrhiza Bunge. , 2010, Journal of proteome research.

[12]  J. Meulman,et al.  Equating, or correction for between-block effects with application to body fluid LC-MS and NMR metabolomics data sets. , 2010, Analytical chemistry.

[13]  I. Wilson,et al.  Methodological considerations in the development of HPLC-MS methods for the analysis of rodent plasma for metabonomic studies. , 2009, Molecular bioSystems.

[14]  Frans M van der Kloet,et al.  Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. , 2009, Journal of proteome research.

[15]  Joshua D. Knowles,et al.  Development and performance of a gas chromatography-time-of-flight mass spectrometry analysis for large-scale nontargeted metabolomic studies of human serum. , 2009, Analytical chemistry.

[16]  L. Willmitzer,et al.  13C isotope-labeled metabolomes allowing for improved compound annotation and relative quantification in liquid chromatography-mass spectrometry-based metabolomic research. , 2009, Analytical chemistry.

[17]  Joshua D. Knowles,et al.  Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. , 2009, Analytical chemistry.

[18]  Monica Chiogna,et al.  A comparison on effects of normalisations in the detection of differentially expressed genes , 2009, BMC Bioinformatics.

[19]  J. Dow,et al.  Applications of mass spectrometry in metabolomic studies of animal model and invertebrate systems. , 2008, Briefings in functional genomics & proteomics.

[20]  Rainer Breitling,et al.  Increasing the mass accuracy of high‐resolution LC‐MS data using background ions – a case study on the LTQ‐Orbitrap , 2008, Proteomics.

[21]  David S. Wishart,et al.  HMDB: a knowledgebase for the human metabolome , 2008, Nucleic Acids Res..

[22]  J. Lindon,et al.  Systems biology: Metabonomics , 2008, Nature.

[23]  J. Dow,et al.  Metabolomic profiling of Drosophila using liquid chromatography Fourier transform mass spectrometry , 2008, FEBS letters.

[24]  Stephen J. Bruce,et al.  Global metabolic profiling analysis on human urine by UPLC-TOFMS: issues and method validation in nutritional metabolomics. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[25]  I. Wilson,et al.  Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[26]  E Holmes,et al.  The mechanism of galactosamine toxicity revisited; a metabonomic study. , 2007, Journal of proteome research.

[27]  Matej Oresic,et al.  Normalization method for metabolomics data using optimal selection of multiple internal standards , 2007, BMC Bioinformatics.

[28]  D. Kell Systems biology, metabolic modelling and metabolomics in drug discovery and development. , 2006, Drug discovery today.

[29]  P. Elliott,et al.  Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. , 2006, Analytical chemistry.

[30]  J. Lindon,et al.  Scaling and normalization effects in NMR spectroscopic metabonomic data sets. , 2006, Analytical chemistry.

[31]  R. Abagyan,et al.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.

[32]  Elaine Holmes,et al.  Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis , 2004, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[33]  T. Ebbels,et al.  Analytical reproducibility in (1)H NMR-based metabonomic urinalysis. , 2002, Chemical research in toxicology.

[34]  D. Massart,et al.  DETERMINATION OF THE REPRESENTATIVITY BETWEEN TWO MULTIDIMENSIONAL DATA SETS BY A COMPARISON OF THEIR STRUCTURE , 1998 .

[35]  C. Becker,et al.  Quantification of proteins and metabolites by mass spectrometry without isotopic labeling. , 2007, Methods in molecular biology.

[36]  A. Smilde,et al.  Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. , 2006, Analytical chemistry.